Abstract
Antibody-drug conjugates (ADCs), a combination of cyto-toxic drugs and antibodies, have emerged as a rising star in cancer therapy. Disitamab vedotin ......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
